23 people spoke in favor of funding the development of an opioid-use disorder treatment using the psychedelic drug ibogaine at the Kentucky Opioid Abatement Advisory Commission s second and final public
By Melissa PatrickKentucky Health NewsTwenty-three people spoke in favor of funding the development of an opioid-use disorder treatment using the psychedelic drug ibogaine with some of the state